A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib
This study is ongoing, but not recruiting participants.
Sponsor:
AB Science
Information provided by (Responsible Party):
AB Science
ClinicalTrials.gov Identifier:
NCT01506336
First received: January 3, 2012
Last updated: September 25, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Primary Completion Date: | September 2011 (Final data collection date for primary outcome measure) |